Search results (44)
« Back to NewsReal world effects of antidepressants
30 December 2024
New study compared real-world effects of different antidepressants with data from randomised controlled trials.
Radical rethink of mental health support for adolescents needed – new study
19 December 2024
Young people have given important insights into what mental health support they prefer and what does not work for them or meet their needs, as part of a major new study of thousands of adolescents.
Could taking a specific anticonstipation drug reduce your risk of depression?
14 August 2024
A new paper suggests that anti-constipation drug, prucalopride, may reduce the risk of experiencing depression in individuals with no past history of mental illness.
Serotonin changes how people learn and respond to negative information – new study
12 August 2024
Increasing serotonin can change how people learn from negative information, as well as improving how they respond to it, according to a new study published in the leading journal Nature Communications.
Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression
5 August 2024
Two pharmacological treatments used for depression affect the brain in completely different ways, shedding light on how the depressed brain gets rebalanced, according to a paper published in the journal Nature Mental Health.
Statin use among people with depression associated with lower mortality
30 May 2024
New study of more than one million people with depression in England shows that statin use is associated with lower mortality and no increased adverse events.
AI to help personalise treatment for depression as part of major trial
13 May 2024
People with depression are being invited to be part of a clinical trial testing a new evidence-based AI treatment tool to personalise antidepressant treatment.
Trial including Oxford will test if drug can reduce depression following brain injury
5 April 2024
Up to 50 per cent of people who suffer a traumatic brain injury (TBI) go on to develop some form of depression in the 10 years following the injury.
New mental health toolkit available for Oxford students on University Mental Health Day
14 March 2024
A free digital mental health toolkit is now available to University of Oxford students as part of a research trial led by the university’s Department of Psychiatry.
Taking a statin at the same time as an antidepressant leads to better treatment adherence
14 November 2023
New study by Oxford University shows that taking a statin at the same time as an antidepressant leads to better treatment adherence, which may be of importance to people with depression.
Tackling mental illness by supporting industry to develop new drugs
11 October 2023
An academic/industry partnership, based at the NIHR Oxford Health Biomedical Research Centre, is helping companies use experimental medicine approaches to speed up development of new drugs to treat psychiatric disorders.
Response to study on esketamine nasal spray
5 October 2023
Leading Oxford consultant psychiatrist Rupert McShane has responded to a new paper on the effectiveness of esketamine nasal spray, a form of ketamine, for treatment-resistant depression.
Husseini Manji awarded international prize in mental health
3 October 2023
Professor Manji is one of the recipients of the 2023 Rhoda and Bernard Sarnat International Prize in Mental Health for the discovery of the rapid antidepressant effects of ketamine.
New tool to streamline prescribing of antidepressants
27 September 2023
A new web tool has been developed to simplify the prescription of antidepressant and antipsychotic drugs.
Young people’s mental health deteriorated at greater rate during the pandemic
21 September 2023
Major new study shows young people’s mental health deteriorated during COVID-19, with higher levels of depression and social, emotional and behavioural difficulties than before the pandemic hit.
'Ketamine may offer hope for treatment-resistant depression'
24 July 2023
Oxford University and Oxford Health NHS Foundation Trust consultant psychiatrist Professor Rupert McShane is calling for ketamine to be used as an option for those patients with severe or very treatment resistant depression being considered for Electroconvulsive Therapy (ECT).
Serotonin booster leads to increased functional brain connectivity
15 June 2023
A new study examining the drug Prucalopride finds it has effects in areas of the human brain that improve cognitive function.
“Looking back on my childhood, I can’t ever remember a time when I didn’t feel negative."
22 May 2023
A data scientist who was able to return to work after taking medication for severe depression as part of an Oxford research trial has urged others to consider taking part in studies.
Psychological Adaptiveness to Critical Events: an introduction to the CIPA study
15 May 2023
Clinical psychologist and Visiting Fellow Omid V. Ebrahimi discusses his work here in Oxford and the study he co-leads in Norway – one of the largest of its kind globally.
Online arts and culture for young people’s mental health – new research programme announced
3 April 2023
- Anxiety
- Child and Adolescent Psychiatry
- Child and adolescent
- Depression
- Mental Health
- Public involvement
Young people will help create an ‘online museum’ as a way of improving their mental health, as part of a new and ground-breaking £2.61m research project.